Inventaire - your friends and communities are your best library

Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders

Published in: Drugs

Date of publication: October 1, 1994

Bibliographic databases:

Cites articles 79

Date

Title

Authors

June 1, 1984

Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine
October 1, 1986

Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man.
August 1, 1986

Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine
January 1, 1987

Studies on the central effects of the H1-antagonist, loratadine
September 1, 1987

Pharmacokinetics and dose proportionality of loratadine
January 1, 1987

Antiallergic activity of loratadine, a non-sedating antihistamine
July 1, 1987

Sedative effects of antihistamines
July 1, 1987

Loratadine: multiple-dose pharmacokinetics
June 1, 1987

Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis
January 1, 1988

The pharmacokinetics of loratadine in normal geriatric volunteers
April 1, 1988

Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis
July 1, 1988

Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticaria
December 1, 1988

Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action
January 1, 1988

A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis
January 1, 1988

The influence of antihistamines on human performance
April 1, 1988

Loratadine, an antihistamine, blocks antigen-and ionophore-induced leukotriene release from human lung in vitro
March 1, 1988

Excretion of loratadine in human breast milk
June 1, 1988

Effects of loratadine (SCH 29851) in suppression of histamine-induced skin wheals
January 1, 1989

Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy
November 1, 1989

Effect of a non-sedative antihistaminic (loratadine) in moderate asthma. A double-blind controlled clinical crossover-trial
November 1, 1989

Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis
October 1, 1989

The effectiveness of the nonsedating antihistamine loratadine plus pseudoephedrine in the symptomatic management of the common cold
June 1, 1989

SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis
April 1, 1989

Effects of nonsedating histamine H1-antagonists on EEG activity and behavior in the cat.
February 1, 1989

Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis
January 1, 1989

Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl
October 1, 1989

Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis
August 1, 1989

Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis
May 1, 1990

Loratadine and dexchlorpheniramine in the treatment of perennial allergic rhinitis in pediatric patients
August 1, 1990

Lack of subsensitivity to loratadine during long-term dosing during 12 weeks
May 1, 1990

A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis
December 1990

Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis

Article -

Welcome to inventaire

The library of your friends and communities

Learn more